Moreover, our results showed that AR mRNA levels were also increased in tissues from HER2+ BC patients regardless of their ER or PgR status (SMD: 0.174; 95% CI: 0.002–0.079; p < 0.001), with moderate heterogeneity (Supplementary Figure S2D). The gene discussed is ERBB2; the disease is breast cancer.